Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism Journal Article
| Authors: | Filippova, O. T.; Kim, S. W.; Cowan, R. A.; Chi, A. J.; Iasonos, A.; Zhou, Q. C.; Broach, V.; Zivanovic, O.; Long Roche, K.; Sonoda, Y.; Gardner, G.; Chi, D. S. |
| Article Title: | Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism |
| Abstract: | Introduction The spleen plays a role in the immune and coagulative responses, yet a splenectomy may be required during ovarian cancer surgery to achieve complete cytoreduction. The aim of the study was to correlate hematologic changes with the development of infection and venous thromboembolism in patients undergoing splenectomy. Methods This single-institution retrospective review includes all patients undergoing splenectomy during cytoreductive surgery for advanced ovarian cancer, March 2001 to December 2016. We compared postoperative hematologic changes (evaluated daily before discharge) in patients developing infection within 30 days' post-surgery (Infection group) with those who did not (No-Infection group). We also compared patients developing venous thromboembolism with those without. Results A total of 265 patients underwent splenectomy. Median age was 64 years (range 22-88): 146 (55%) patients had stage IIIC and 114 (43%) patients had stage IV. The majority, 201 (76%) patients underwent splenectomy during primary debulking. A total of 132 (50%) patients comprised the Infection group (most common: urinary tract infection, 54%). Median time from surgery to infection was 8 days (range, 0-29). After initial rise in white blood cell count in both groups, the Infection group had a second peak on postoperative day 10 (median 16.6K/mcL, IQR 12.5-21.2) not seen in the No-Infection group (median 12K/mcL, IQR 9.3-16.3). A total of 40 (15%) patients developed venous thromboembolism, median time of 6.5 days (range, 1-43). All patients demonstrated a continuous rise in platelets during postoperative days 0-15. Thrombocytosis was present in 38/40 (95%) patients with venous thromboembolism vs 183/225 (81%) patients without (P=0.036). Median days with thrombocytosis was higher in venous thromboembolism (8 days, range 1-15) vs non groups (6 days, range 1-16, P=0.049). Conclusion We identified initial leukocytosis after splenectomy in all patients. The Infection group had a second peak in white blood cell count on postoperative day 10, not present in the No-Infection group. Among patients with venous thromboembolism, thrombocytosis was more frequent and of longer duration. © IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. |
| Keywords: | ovarian cancer; surgery; surgical procedures, operative |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 30 |
| Issue: | 8 |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2020-08-01 |
| Start Page: | 1183 |
| End Page: | 1188 |
| Language: | English |
| DOI: | 10.1136/ijgc-2020-001368 |
| PUBMED: | 32665236 |
| PROVIDER: | scopus |
| PMCID: | PMC8369877 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 2 November 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work